How The Cooper Companies, Inc. stacks up

COO · against 152 other Healthcare companies of similar size

Overall

56/ 100

Below the middle of the pack.

Ranked #84 of 153 · scores higher than 43% of peers

Bars: peers in each 10-point band of the overall score

41 peers with an overall score of 50–59, including COO · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#41 of 158Score 70 / 100 · beats 75%Growth#77 of 147Score 57 / 100 · beats 47%Profitability#102 of 153Score 60 / 100 · beats 32%Risk#90 of 156Moderate relative risk · safety 36 · beats 43%

Ranking by overall score

Top 5 and the companies ranked around COO

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Lupin LimitedLUPIN.NS · India	921.9B INR (≈$11.1B)	82	84	80	94	0 / 2
2	Asahi Intecc Co., Ltd.7747.T · Japan	936.1B JPY (≈$6.4B)	80	65	86	94	0 / 2
3	Globus Medical, Inc.GMED · US-listed	10.7B USD	78	77	85	84	0 / 2
3	Krystal Biotech, Inc.KRYS · US-listed	9.0B USD	78	50	80	94	0 / 2
3	Ligand Pharmaceuticals IncorporatedLGND · US-listed	6.3B USD	78	50	90	86

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

⋯
78	Smith & Nephew plcS1NN34.SA · Brazil	69.1B BRL (≈$12.4B)	57	78	59	61	2 / 2